TABLE 1

Patient Characteristics

Patient no.	Age (y)	cTNM stage	Tumor site	Scan TD (Gy)	SUVmax^*	pTV (cm³)^*	Treatment regimen	RT plan
1	67	cT3N1M0(III)	Cervical	0, 30, 40, 46	5.7	12.5	RT alone	Conventional
2	49	cT3N1M0(III)	Mid thoracic	0, 10, 20	8.9	20.6	CCRT	3DCRT
3	68	cT3N1M1(IVb)	Mid thoracic	0, 30	7.5	23.8	Sequential chemo-RT	Conventional
4	56	cT3N1M0(III)	Cervical	0, 10, 20	7.8	24.9	CCRT	3DCRT
5	67	cT3N1M1(IVb)	Mid thoracic	0, 30, 50	1.1	0	Sequential chemo-RT	3DCRT
6	63	cT4N0M0(IIb)	Upper thoracic	0, 10, 20	11.9	26.4	CCRT	3DCRT
7	69	cT3N1M0(III)	Cervical	0, 30, 40	15.3	35.7	CCRT	3DCRT
8	54	cT3N0M0(IIb)	Upper thoracic	0, 30, 40	5.9	11.5	CCRT	3DCRT
9	81	cT3N0M0(IIa)	Mid thoracic	0, 20, 40	7.4	18.7	RT alone	3DCRT
10	48	cT3N1M0(III)	Cervical	0, 10, 20	9.6	27.5	CCRT	3DCRT
11	64	cT3N0M0(IIa)	Mid thoracic	0, 30, 40, 50	15.2	34.8	RT alone	Conventional
12	59	cT4N0M0(III)	Mid thoracic	0, 20	6.6	16.3	C225 + CCRT	3DCRT
13	56	cT3N1M0(III)	Mid thoracic	0, 10, 40	13.9	29.5	CCRT	3DCRT
14	70	cT3N0M0(IIa)	Upper thoracic	0, 6, 30	13.6	28.5	CCRT	3DCRT
15	62	cT3N1M0(III)	Upper thoracic	0, post-RT	9.1	21.8	C225 + CCRT	IMRT
16	45	cT4N1M0(III)	Mid thoracic	0, post-RT	11.2	23.9	C225 + CCRT	IMRT
17	48	cT3N0M0(IIa)	Upper thoracic	0, 10, 20	9.3	21.5	CCRT	3DCRT
18	52	cT3N1M0(III)	Mid thoracic	0, 10, 20	10.5	22.1	CCRT	3DCRT
19	63	cT4N0M1(IVb)	Lower thoracic	0, 2	7.0	23.8	RT alone	Conventional
20	59	cT3N1M0(III)	Cervical	0, 0, 20	10.2	21.6	CCRT	3DCRT
21	67	cT4N0M0(III)	Cervical	0, 10, 20	15.8	35.7	CCRT	3DCRT

↵* Of primary tumor on baseline ¹⁸F-FLT scan.
pTV = proliferation target volume; RT = radiotherapy; CCRT = concurrent chemoradiotherapy; 3DCRT = 3-dimensional conformal radiotherapy; IMRT = intensity-modulated radiotherapy.